Biotechnology

By Maggie Fox, health and science editor Maggie Fox, health and science Editor-Mountain Nov 22, 6: 19 h. HITTITES WASHINGTON (Reuters)-Christopher Goodrich, Portland, Oregon, can't wait for a needle in his eyes. Goodrich was expected to be one of the first patients were enrolled in clinical trial this only a sound States food and drug administration, only the second judgment approved anywhere in the world test globil human milk stem in the people. Advanced cell technology, a Massachusetts-based company biotechnologie did evil to bring globil human milk stem in the lab to the clinic, recrutement 12 patients start in Oregon, Massachusetts and eye condition called scarce Stargardt (k will be put to death. Goodrich, 55, retired last year of his work as Coordinator for services to the University of Portland State when Stargardt (k death completely inexplicable and suddenly take a turn for the worse. Like most patients Goodrich, saw the vision, it gets worse steadily from his earliest da...

A trial to test Stem Cells as the Macular Dystrophy Stargardt's end-of-life care Federal officials have again been approved through the use of human embryonic stem cells--currently, only the second seeks to deal with the rare disease that causes blindness of young clinical research. Advanced cell technology, biotechnology company has its registered office or place of Marlborough, mass., said today that it received the green light of the u.s. food and drug administration; at the beginning of the investigation, the company expects to begin next year 12 patients diagnosed Macular Dystrophy Stargardt 's. Condition, which is at present an incurable, destroys the progressive Vision is about 10 at the beginning of the age. Researchers to Inject 50 000 and 200 000 healthy Retinal cells derived from embryonic stem cells into account between each patient's eyes; -animal cells helped prevent Vision loss and returns some in sight. "I think this marks the beginning of a new era fo...